Upgrade to see committee overlap, performance context, and full expert analysis.
SPOT congressional trades
7 matched disclosures
SPOT congressional trades snapshot
This page summarizes public STOCK Act disclosures involving SPOT. It is useful for seeing which lawmakers reported SPOT transactions, how many filings are visible, the buy/sell mix, and whether the newest public filing describes a recent or delayed trade.
Dec 15, 2025
Public House and Senate STOCK Act disclosures normalized by Congressional Trader.
Filing date can trail transaction date. This page is for research and monitoring, not investment advice.
What the SPOT congressional trade page shows
Congressional Trader tracks 7 public STOCK Act disclosures for SPOTacross 6 lawmakers. This page separates purchases from sales, shows filing delays, and links each disclosure back to the individual politician profile when available.
The most recent SPOT filing shown here was filed on Dec 15, 2025 by Gilbert Ray Cisneros as a purchase. Related lawmakers include Jefferson Shreve, Bruce Westerman, Gilbert Ray Cisneros, Josh Gottheimer, Robert P. Bresnahan.
Top lawmakers for SPOT
Pro performance summary
Unlock 30/90-day post-trade summaries, committee overlap, and CSV-oriented research views for high-intent ticker research.
Compare Pro plansUpgrade to see committee overlap, performance context, and full expert analysis.
Upgrade to see committee overlap, performance context, and full expert analysis.
Upgrade to see committee overlap, performance context, and full expert analysis.
Upgrade to see committee overlap, performance context, and full expert analysis.
Upgrade to see committee overlap, performance context, and full expert analysis.
Upgrade to see committee overlap, performance context, and full expert analysis.
FAQ
Which lawmakers traded SPOT?
Recent SPOT disclosures include Jefferson Shreve, Bruce Westerman, Gilbert Ray Cisneros, Josh Gottheimer, Robert P. Bresnahan.
What is the buy/sell mix for SPOT?
The visible sample currently shows 6 purchases and 1 sales or partial sales.
Should I trade based on SPOT disclosures?
No. This page summarizes public filings for research and monitoring. It is not investment advice.